K
Kristina Garuoliene
Researcher at Vilnius University
Publications - 29
Citations - 1962
Kristina Garuoliene is an academic researcher from Vilnius University. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 20, co-authored 23 publications receiving 1718 citations.
Papers
More filters
Journal ArticleDOI
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Jakub Adamski,Brian Godman,Brian Godman,Brian Godman,Gabriella Ofierska-Sujkowska,Bogusława Osińska,Harald Herholz,Kamila Wendykowska,Ott Laius,Saira Jan,Catherine Sermet,Corrine Zara,Marija Kalaba,Roland Gustafsson,Kristina Garuoliene,Alan Haycox,Silvio Garattini,Lars L. Gustafsson +17 more
TL;DR: There are only a limited number of situations where 'risk sharing' schemes should be considered as well as factors thatShould be considered by payers in advance of implementation, and whether systematic evaluations have been built into proposed schemes.
Journal ArticleDOI
International trends in clozapine use: a study in 17 countries
Christian Bachmann,Lise Aagaard,Miguel Bernardo,Lena Brandt,Marta Cartabia,Antonio Clavenna,A. Coma Fusté,Kari Furu,Kristina Garuoliene,Falk Hoffmann,Samantha A. Hollingworth,Krista F. Huybrechts,Luuk J. Kalverdijk,Koji Kawakami,Helle Kieler,Takuya Kinoshita,S. C. López,Jorge Enrique Machado-Alba,Manuel Enrique Machado-Duque,Mufaddal Mahesri,Prasad S. Nishtala,Daniele Piovani,Johan Reutfors,Leena K. Saastamoinen,Izumi Sato,Catharina C. M. Schuiling-Veninga,Yu-Chiau Shyu,Dan Siskind,Svetlana Skurtveit,Hélène Verdoux,Liang-Jen Wang,C. Zara Yahni,Helga Zoega,David Taylor +33 more
TL;DR: This study aimed to assess clozapine use trends on an international scale, using standardised criteria for data analysis.
Journal ArticleDOI
International trends in antipsychotic use: A study in 16 countries, 2005-2014
Oskar Halfdanarson,Helga Zoega,Lise Aagaard,Miquel Bernardo,Lena Brandt,Anna Coma Fusté,Kari Furu,Kristina Garuoliene,Falk Hoffmann,Krista F. Huybrechts,Luuk J. Kalverdijk,Koji Kawakami,Helle Kieler,Takuya Kinoshita,Melisa Litchfield,Soffy C. López,Jorge Enrique Machado-Alba,Manuel Enrique Machado-Duque,Mufaddal Mahesri,Prasad S. Nishtala,Sallie-Anne Pearson,Johan Reutfors,Leena K. Saastamoinen,Izumi Sato,Catharina C. M. Schuiling-Veninga,Yu-Chiau Shyu,Svetlana Skurtveit,Hélène Verdoux,Liang-Jen Wang,Corinne Zara Yahni,Christian Bachmann +30 more
TL;DR: In the majority of populations, antipsychotic utilisation and especially the use of atypical antipsychotics increased over time, and quetiapine, risperidone, and olanzapine were most frequently prescribed.
Journal ArticleDOI
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Brian Godman,William H. Shrank,Morten Andersen,Christian Berg,Iain Bishop,Thomas Burkhardt,Kristina Garuoliene,Harald Herholz,Roberta Joppi,Marija Kalaba,Ott Laius,Diane McGinn,Vita Samaluk,Catherine Sermet,Ulrich Schwabe,Inês Teixeira,Lesley Tilson,F. Cankat Tulunay,Vera Vlahović-Palčevski,Kamila Wendykowska,Björn Wettermark,Corinne Zara,Lars L. Gustafsson +22 more
TL;DR: This cross-national study has demonstrated considerable variation in the utilization and expenditure of PPIs and statins across Europe, providing opportunities to further improve prescribing efficiency.
Comparing Policies to Enhance Prescribing Efficiency in Europe Through Increasing Generic Utilization: Changes Seen and Global Implications
William H. Shrank,Brian Godman,Morten Andersen,Christian Berg,Iain Bishop,Thomas Burkhardt,Kristina Garuoliene,Harald Herholz,Roberta Joppi,Marija Kalaba,Ott Laius,Diane McGinn,Vita Samaluk,Catherine Sermet,Ulrich Schwabe,Inês Teixeira,Lesley Tilson,FC Tulunay,Vera Vlahović-Palčevski,Kamila Wendykowska,B. Wettermark,Corrine Zara,Lars L. Gustafsson +22 more
TL;DR: In this article, the authors evaluated the influence of different demand-side measures to enhance the prescribing of generics in ambulatory care based on cross-national comparisons and found that a combination of education, prescribing targets and financial incentives had the greatest influence on enhancing the utilization of omeprazole and simvastatin.